A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT01303237 · TERMINATED

Trial details

NCT number: NCT01303237
Sponsor: Merck KGaA, Darmstadt, Germany
Status: TERMINATED
Study type: OBSERVATIONAL

Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck LA SCCHN

Start date: 2011-02-28
Primary completion: 2013-06-30
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.